2012 Taubman Prize
For Excellence in Translational Medical Science
This award is presented annually by the A. Alfred Taubman Medical Research Institute at the University of Michigan. It is meant to recognize work in the crucial field of translational research being conducted by the clinician-scientist who has done the most to transform laboratory discoveries into clinical applications for patients suffering from disease.
Prize: $100,000
Eligibility:
- International scientists are eligible.
- U-M scientists are excluded.
- Self-nomination is permitted.
Judging Criteria:
- Significant contribution to translating basic research findings into medical practice
- The manner in which nominee’s clinical activities connects to his or her laboratory research
- Deadline: April 15, 2012
Announcement of Winner:
- At the annual Taubman Institute Symposium in October 2012. The winner will be asked to serve as the keynote speaker at that event.
Nomination Form
Nomination Guidelines
For a nomination to be considered by the selection committee, the following items must be submitted with the completed nomination form:
- A letter of nomination detailing the individual’s extraordinary or sustained contribution to…
- The curriculum vitae of the nominee
- A bibliography of significant publications
- Two additional letters of support
Electronic submissions are encouraged. Incomplete nominations will not be presented to the nomination committee. The deadline for receiving nominations is April 15, 2012.
If you have any questions, please email This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
Help Us Make A Difference. Make A Donation That Could Save Lives.
Taubman Emerging Scholars Program
Request for applications
Applications are being accepted for the Taubman Institute Emerging Scholars Program.
The applicant must be a junior member of the faculty at the University of Michigan; generally, that means holding an assistant professor title. The applicant must have either an M.D. or an M.D./Ph.D. It is required that candidates both conduct basic research and treat patients.
Applicants should submit a two-to-three page research proposal, as well as a current CV. Priority will be given to proposals involving translational research. Please submit material to This e-mail address is being protected from spambots. You need JavaScript enabled to view it. . The deadline is May 7, 2012.
Young Friends host festive NYC fundraiser
Reception introduced scholar candidate Dr. Parag Patil
About 125 supporters of cutting-edge medical research mixed socializing and science May 9 at a cocktail party in Manhattan hosted by the Young Friends of the Taubman Institute's New York City chapter.
The event introduced Dr. Parag Patil, a University of Michigan physician-researcher and a prospective Young Friends Emerging Scholar. Here's a clip from Dr. Patil's appearance on the TV program "The Doctors," where he demonstrates how deep-brain stimulation has helped a patient with Parkinson's disease.
Emerging Scholars are early-career clinician-scientists who show great promise in research aimed at new cures or treatments; through the Taubman Institute, donors support them with three-year grants while their labs earn the credentials to win broader funding support.
The Young Friends event, which raised a significant contribution toward the Emerging Scholars program, was held at the ABC Carpet & Home showrooms at 888 Broadway, Attendees enjoyed cocktails, appetizers, a silent auction and a presentation by Dr. Patil. The silent auction included jewelry, fashion items, a Botox consultation and treatment, Morgan Hotel Group rooms and the opportunity to bid on a meeting and photo with former President William Jefferson Clinton.
Taubman Research
Dr. Max Wicha: Some treatments actually increase cancer stem cells
Avastin and Sutent have been found to increase the growth of breast cancer stem cells in mice, according to Taubman Scholar Dr. Max Wicha, director of the U-M Comprehensive Cancer Center.
